What is the official website of BioPharm International ?

The official website of BioPharm International is http://www.biopharminternational.com.

What is BioPharm International's cybersecurity risk score?

BioPharm International has an AI-generated cybersecurity risk score of 749 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has BioPharm International experienced?

According to Rankiteo, BioPharm International currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has BioPharm International been affected by any supply chain cyber incidents ?

According to Rankiteo, BioPharm International has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does BioPharm International have SOC 2 Type 1 certification ?

According to Rankiteo, BioPharm International is not certified under SOC 2 Type 1.

Does BioPharm International have SOC 2 Type 2 certification ?

According to Rankiteo, BioPharm International does not hold a SOC 2 Type 2 certification.

Does BioPharm International comply with GDPR ?

According to Rankiteo, BioPharm International is not listed as GDPR compliant.

Does BioPharm International have PCI DSS certification ?

According to Rankiteo, BioPharm International does not currently maintain PCI DSS compliance.

Does BioPharm International comply with HIPAA ?

According to Rankiteo, BioPharm International is not compliant with HIPAA regulations.

Does BioPharm International have ISO 27001 certification ?

According to Rankiteo,BioPharm International is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does BioPharm International operate in ?

BioPharm International operates primarily in the Book and Periodical Publishing industry.

How many employees does BioPharm International have ?

BioPharm International employs approximately 2 people worldwide.

Does BioPharm International own any subsidiaries ?

BioPharm International presently has no subsidiaries across any sectors.

How many LinkedIn followers does BioPharm International have ?

BioPharm International's official LinkedIn profile has approximately 2,550 followers.

What is the NAICS classification code for BioPharm International ?

BioPharm International is classified under the NAICS code 511, which corresponds to Publishing Industries (except Internet).

Does BioPharm International have a Crunchbase profile ?

No, BioPharm International does not have a profile on Crunchbase.

Does BioPharm International have a LinkedIn profile ?

Yes, BioPharm International maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/biopharm-international.

How many cybersecurity incidents has BioPharm International experienced ?

As of July 22, 2026, Rankiteo reports that BioPharm International has experienced 2 cybersecurity incidents.

How many peer or competitor companies does BioPharm International have ?

BioPharm International has an estimated 5,149 peer or competitor companies worldwide.

What types of cybersecurity incidents has BioPharm International faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Cyber Attack.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

BioPharm International

Boost Score +25 with badge (5 left)

749

/1000

Moderate

774

/1000

Fair

BioPharm International Vendor Cyber Rating & Cyber Score

biopharminternational.com

Add Your Compliance Badge

BioPharm International integrates the science and business of biopharmaceutical development, and manufacturing. We provide practical, peer-reviewed technical articles to enable biopharmaceutical professionals to perform their jobs more effectively. We believe that technical decisions are also business decisions and give readers the tools to make both sound business and technical decisions.

BioPharm International A.I CyberSecurity Scoring

Scoring History

BioPharm International

BioPharm International CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

BioPharm Internatio...

Cyber Attack

08/2022

MJH018261022

BioPharm Internatio...

Breach

5/2018

PHA323072725

Loading…

A.I.

BioPharm International Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for BioPharm International

Incidents vs Book and Periodical Publishing Industry Avg (This Year)

No incidents recorded for BioPharm International in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for BioPharm International in 2026.

Incident Types BioPharm International vs Book and Periodical Publishing Industry Avg (This Year)

No incidents recorded for BioPharm International in 2026.

Incident History - BioPharm International (X = Date, Y = Severity)

Loading…

SUBSIDIARY

BioPharm International Subsidiaries

BioPharm International

Book and Periodical Publishing

Website: http://www.biopharminternational.com

Company Size: 501-1,000 employees

MJH Life Sciences®Media Production

Pharmacy TimesBook and Periodical Publishing

Pharmaceutical Commerce MagazinePharmaceutical Manufacturing

Drug TopicsBook and Periodical Publishing

AJMC - The American Journal of Managed CareBook and Periodical Publishing

AJMC: Center on Health Equity & AccessInternet News

Urology TimesBook and Periodical Publishing

Pharmaceutical TechnologyBook and Periodical Publishing

Targeted OncologyOnline Audio and Video Media

Ophthalmology Times EuropeMedia Production

Ophthalmology TimesMedia Production

Modern RetinaMedia Production

HCPLiveMedia Production

Managed Healthcare ExecutiveMedia Production

PER®Education Management

American Journal of Hematology / Oncology®Wellness and Fitness Services

Spectroscopy MediaBook and Periodical Publishing

Psychiatric TimesMedia Production

Contagion_LiveBook and Periodical Publishing

Oncology Nursing NewsBook and Periodical Publishing

Medical EconomicsBook and Periodical Publishing

Physicians PracticeBook and Periodical Publishing

Dental Products ReportBook and Periodical Publishing

Optometry TimesMedia Production

CMINon-profit Organizations

Cannabis Science ConferenceEvents Services

Specialty Pharmacy TimesMedia Production

FormularyWatchBook and Periodical Publishing

Contemporary OB/GYNBook and Periodical Publishing

CURE Media GroupBook and Periodical Publishing

Pharmacy Benefit Management InstitutePharmaceutical Manufacturing

Applied Clinical Trials MagazineBook and Periodical Publishing

Contemporary PediatricsBook and Periodical Publishing

Cannabis Patient CareBook and Periodical Publishing

MJH Thought LeadersMedia Production

Dental Lab ProductsBook and Periodical Publishing

Medical World NewsBroadcast Media Production and Distribution

Modern HygienistMedia Production

Total PharmacyBook and Periodical Publishing

meetmyMSLHospitals and Health Care

NeurologyLiveOnline Audio and Video Media

Association of Cancer Care CentersHospitals and Health Care

Institute for Clinical Immuno-Oncology (ICLIO)Hospitals and Health Care

LCGC InternationalBook and Periodical Publishing

Turbomachinery InternationalBook and Periodical Publishing

Cancer NetworkBook and Periodical Publishing

Cannabis Science and TechnologyBook and Periodical Publishing

OncLiveBook and Periodical Publishing

Dermatology TimesBook and Periodical Publishing

Pharmaceutical ExecutiveBook and Periodical Publishing

dvm360®Veterinary Services

The Center for BiosimilarsBook and Periodical Publishing

Nutritional OutlookWellness and Fitness Services

Diagnostic Imaging®Online Audio and Video Media

Infection Control Today®Online Audio and Video Media

Loading…

BioPharm International Similar Companies

Forbes

forbes.com

Forbes Media is a global media, branding and technology company, with a focus on news and information about business, investing, technology, entrepreneurship, leadership and affluent lifestyles. The company publishes Forbes, Forbes Asia, and Forbes Europe magazines as well as Forbes.com. The Forbes brand today reaches more than 94 million people worldwide with its business message each month through its magazines and 37 licensed local editions around the globe, Forbes.com, TV, conferences, research, social and mobile platforms. Forbes Media’s brand extensions include conferences, real estate, education, financial services, and technology license agreements. Forbes is an equal opportunity employer.

Loading…

NEWS

BioPharm International CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

December 16, 2025 08:00 AM

SK Capital Partners supports Swixx BioPharma’s global expansion

US-based private investment company SK Capital Partners' affiliate is to invest in Swixx BioPharma to support its growth and expansion.

Read Article

September 09, 2025 07:00 AM

PDA 2025: Data Governance and AI's Impact on Drug Manufacturing

Data integrity and quality are paramount for drug discovery, manufacturing efficiency, regulatory compliance, and patient safety.

Read Article

August 14, 2025 07:00 AM

ElevateBio BaseCamp Achieves First Multi-Modality ICMC Certification in Commercial CGT Manufacturing

Third-party ICMC certification verifies multi-modality manufacturing readiness, meeting US and EU standards for advanced genetic therapies.

Read Article

April 02, 2025 07:00 AM

BIOPHARM WINS EXCELLENCE IN GENERIC MEDICINE DEVELOPMENT IN ALGERIA AT THE GLOBAL BRAND AWARDS 2024

Biopharm, a leading pharmaceutical company in Algeria, has been awarded the prestigious title of 'Excellence in Generic Medicine Development...

Read Article

March 11, 2025 07:00 AM

Progressing Toward Full Automation in Biomanufacturing

Advances in manufacturing for biologics and new biotherapeutics are often based on current trends and/or changes or upgrades in equipment...

Read Article

March 03, 2025 08:00 AM

Can Arbutus Win Billions? Patent Fight Against Moderna's COVID Vaccine Goes Global

Genevant Sciences and Arbutus Biopharma (ABUS) have initiated five international patent infringement lawsuits against Moderna across 30 countries.

Read Article

January 24, 2025 08:00 AM

EU to target AI, biotech, cheap energy in global competitiveness push

AI, biotech and affordable clean energy will be the focus of an EU drive to make the bloc globally competitive and ensure it keeps pace with...

Read Article

January 15, 2025 08:00 AM

Biotech Battlefield

“Only by grasping the core technologies in our own hands will we be able to truly grasp the initiative in competition and development,...

Read Article

December 10, 2024 08:00 AM

2025 life sciences outlook

While several potentially disruptive forces could reshape the life sciences industry in 2025, the vast majority (75%) of global life...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-63261

SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). A low-privileged authenticated user can send a specially crafted request to a Kibana machine learning feature, causing the server to exhaust available memory and become unavailable to all users.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/kibana-8-19-19-9-3-8-9-4-4-security-update-esa-2026-72/388575

CVE-2026-63260

SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). An authenticated attacker with low-privilege access can trigger a denial of service condition in Kibana by sending a specially crafted, oversized request payload. Processing this user-supplied input requires resource-intensive memory allocation that can exhaust the available heap memory in the Kibana process, causing it to crash and become unavailable to all users.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/kibana-8-19-19-9-3-8-9-4-4-security-update-esa-2026-71/388574

CVE-2026-63259

SUMMARY

Authorization Bypass Through User-Controlled Key (CWE-639) in Kibana can lead to information disclosure via user-supplied identifiers that reference scheduled query result data from Kibana Spaces the requester is not authorized to access.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 4.3)

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/kibana-9-4-4-security-update-esa-2026-70/388573

CVE-2026-63145

SUMMARY

Incorrect Authorization (CWE-863) in Kibana can lead to integrity compromise of Machine Learning audit and notification records via Accessing Functionality Not Properly Constrained by ACLs (CAPEC-1). A vulnerability exists in Kibana's Machine Learning functionality where a Machine Learning management endpoint performs an insufficient authorization check. The endpoint validates only a coarse privilege level but does not verify that the requesting user has access to the specific Machine Learning job or notification resources provided in the request. As a result, a low-privileged user with Machine Learning access in any Kibana space can manipulate Machine Learning audit and notification records for arbitrary jobs—including jobs in other spaces or belonging to other users—by leveraging Kibana's internally elevated credentials to write to restricted Machine Learning system indices that the user cannot access directly.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 4.3)

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N

Impact Score

1.4

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/kibana-8-19-19-9-3-8-9-4-4-security-update-esa-2026-69/388572

CVE-2026-63144

SUMMARY

Uncontrolled Recursion (CWE-674) in Elasticsearch can lead to denial of service via a specially crafted search request submitted by a low-privileged authenticated user. A user with read-level index access can submit a request that triggers unbounded recursive processing within the Elasticsearch query evaluation component, causing a fatal error that terminates the affected node. In single-node deployments, this results in complete service outage; in multi-node clusters, it causes repeated node restarts and sustained availability degradation.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/elasticsearch-8-19-19-9-3-8-9-4-4-security-update-esa-2026-68/388571

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…